Chemed (NYSE:CHE – Get Free Report) and LifeStance Health Group (NASDAQ:LFST – Get Free Report) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for Chemed and LifeStance Health Group, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Chemed | 0 | 4 | 3 | 0 | 2.43 |
| LifeStance Health Group | 0 | 4 | 5 | 1 | 2.70 |
Chemed presently has a consensus target price of $603.00, indicating a potential upside of 9.79%. LifeStance Health Group has a consensus target price of $14.86, indicating a potential upside of 7.58%. Given Chemed’s higher possible upside, research analysts clearly believe Chemed is more favorable than LifeStance Health Group.
Volatility and Risk
Chemed has a beta of 0.5, suggesting that its share price is 50% less volatile than the S&P 500. Comparatively, LifeStance Health Group has a beta of 1.35, suggesting that its share price is 35% more volatile than the S&P 500.
Valuation & Earnings
This table compares Chemed and LifeStance Health Group”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Chemed | $2.66 billion | 2.69 | $265.24 million | $20.90 | 26.28 |
| LifeStance Health Group | $1.68 billion | 3.13 | $9.66 million | $0.19 | 72.68 |
Chemed has higher revenue and earnings than LifeStance Health Group. Chemed is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
95.8% of Chemed shares are owned by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are owned by institutional investors. 3.3% of Chemed shares are owned by company insiders. Comparatively, 3.5% of LifeStance Health Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Profitability
This table compares Chemed and LifeStance Health Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Chemed | 10.61% | 35.18% | 19.43% |
| LifeStance Health Group | 4.29% | 4.82% | 3.30% |
Summary
Chemed beats LifeStance Health Group on 8 of the 15 factors compared between the two stocks.
About Chemed
Chemed Corporation is a U.S.-based company operating through two principal businesses: VITAS Healthcare, which provides hospice and palliative care, and Roto-Rooter, which offers plumbing, drain-cleaning and water-restoration services. VITAS serves patients with serious illnesses through home-based care and services in hospice facilities and other care settings. Roto-Rooter serves residential and commercial customers with plumbing and drain services, as well as cleanup and restoration following water damage.
About LifeStance Health Group
LifeStance Health Group, Inc. is a U.S. provider of outpatient mental health services. The company offers care through in-person clinics and virtual appointments, connecting patients with behavioral health professionals. Its services include psychotherapy, psychiatric evaluations and medication management. LifeStance’s clinicians treat a range of mental health conditions, including anxiety, depression, attention-deficit/hyperactivity disorder and mood disorders. Founded in 2017, LifeStance has expanded its network across the United States.
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.
